Biosensor methods having enhanced stability and hematocrit performance
View Patent ↗The present invention relates to electrochemical sensor strips and methods of determining the concentration of an analyte in a sample or improving the performance of a concentration determination. The electrochemical sensor strips may include at most 8 μg/mm 2 of a mediator. The strips, the strip reagent layer, or the methods may provide for the determination of a concentration value having at least one of a stability bias of less than ±10% after storage at 50° C. for 4 weeks when compared to a comparison strip stored at −20° C. for 4 weeks, a hematocrit bias of less than ±10% for whole blood samples including from 20 to 60% hematocrit, and an intercept to slope ratio of at most 20 mg/dL. A method of increasing the performance of a quantitative analyte determination also is provided.
1. A method of determining the concentration of an analyte in a sample, comprising:
applying a sample to an electrochemical sensor strip, the senor strip including a first electrode, the first electrode including at least one first layer on a first conductor, the at least one first layer including an enzyme system and at most 8 μ/mm 2 of a mediator,
where the mediator assists in transferring electrons between the analyte in the sample and the first conductor;
applying a pulse sequence to the sample, the pulse sequence comprising at least 2 duty cycles within 3 to 14 seconds, where each duty cycle comprises an excitation and a relaxation,
where the relaxation of each duty cycle provides an output current reduction to one-half or less of a current flow at an excitation maxima;
determining current measurements from the sample responsive to the pulse sequence; and
determining the concentration of the analyte in the sample from the current measurements, the determined concentration having at least one of a stability bias of less than ±10%, a hematocrit bias of less than ±10% for whole blood samples over a 20 to 60% hematocrit range, and an intercept to slope ratio of at most 20 mg/dL.
2. The method of claim 1 , the pulse sequence comprising at least 3 duty cycles within 9 seconds.
3. The method of claim 1 , where the pulse sequence is complete in at most 5 seconds.
4. The method of claim 1 , where the determining the concentration of the analyte in the sample includes determining the concentration of the analyte in the sample from the currents measurement taken within 2 seconds from the application of the pulse sequence.
5. The method of claim 1 , where the excitations each have a duration from 0.01 to 3 seconds.
6. The method of claim 1 , where the excitations have a summed duration of at most 10 seconds.
7. The method of claim 1 , where the excitations are of amplitudes having a difference within 500 mV.
8. The method of claim 1 , where the excitations comprise at most 45% of the time of the pulse sequence.
9. The method of claim 1 , where the relaxations each have a duration of from 0.2 to 3 seconds.
10. The method of claim 9 , where the relaxation is responsive to an open circuit.
11. The method of claim 1 , where the pulse sequence includes an initial excitation from 0.75 to 3 seconds in duration, where the initial excitation is longer in duration than the excitations of the duty cycles.
12. The method of claim 1 , where the stability bias is less than ±5%.
13. The method of claim 1 , where the stability bias is less than ±5% after storage at 50° C. for 4 weeks when compared to a comparison strip stored at -20° C. for 4 weeks.
14. The method of claim 1 , where the hematocrit bias is less than ±5% for whole blood samples including from 20 to 60% hematocrit.
15. The method of claim 1 , where the intercept to slope ratio is at most 10 mg/dL.
16. The method of claim 1 , where 45% or less of the total time of the method is spent oxidizing the sample.
17. The method of claim 1 , where the relaxation is responsive to an open circuit.
18. The method of claim 1 , where the pulse sequence comprises at least 3 duty cycles within 30 seconds.